ACACA and metabolic dysfunction-associated steatohepatitis: Furthermore, because ACC inhibition has been reported to reduce hepatic steatosis but elevate plasma triglyceride concentrations in mice, rats and patients with NASH [20, 31], we also monitored its influence on plasma parameters to investigate the usefulness of ACC dual inhibition.